Overview
- 6 public-safe observations are available for this inspection.
- 3 structured CFR citations are represented.
- 1 investigator is tied to this Form 483.
Inspectional observations
Each observation cites the regulation FDA found the firm out of compliance with.
26 May 2026
ISO 13485:2016 Clause 6.1(a)
Resources for quality management system have not been determined or provided
Cited by Katarzyna Plona
26 May 2026
ISO 13485:2016 Clause 6.1(a)
Resources for quality management system have not been determined or provided
Cited by Katarzyna Plona
26 May 2026
ISO 13485:2016 Clause 7.4.3
Purchased product verification activities not established or implemented
Cited by Katarzyna Plona
Inspected site
BCBiowave CorporationWestport, United States
Inspection team
Cited regulations
CFR citations associated with this Form 483.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 803.50(a)(2) | Cited across public-safe Form 483 observations | 2x |
| ISO 13485:2016 Clause 6.1(a) | Cited across public-safe Form 483 observations | 2x |
| ISO 13485:2016 Clause 7.4.3 | Cited across public-safe Form 483 observations | 2x |
Full 483 report
Get the verbatim text of all 6 observations
The full inspection record, as Atlas holds it, so your team sees exactly what was cited and how it was answered.
- The site's full inspection history around this Form 483
- Whether these citations escalated to a warning letter
- The investigators involved and the citations they repeat elsewhere